Bausch Health Companies (BHC) Other Non-Current Liabilities (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Other Non-Current Liabilities came in at $763.0 million in Q1 2026, little changed year-on-year from $761.0 million in Q1 2025, and down 3.78% quarter-over-quarter from $793.0 million in Q4 2025.

Bausch Health Companies (BHC) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Other Non-Current Liabilities across 18 years of filings, most recently posting $763.0 million for Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $763.0 million, changed 0.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $763.0 million (changed 0.26% YoY), and the FY2025 annual result was $793.0 million, up 11.22% from the prior year.
  • Other Non-Current Liabilities came in at $763.0 million for Q1 2026 at Bausch Health Companies, down from $793.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $877.0 million in Q2 2025 to a low of $524.0 million in Q2 2022.
  • The 5-year median for Other Non-Current Liabilities is $746.0 million (2023), against an average of $733.4 million.
  • Across the five-year window, Other Non-Current Liabilities plunged 46.26% in 2022 and jumped 42.18% in 2023, its largest moves.
  • Bausch Health Companies' Other Non-Current Liabilities stood at $741.0 million in 2022, then climbed by 4.72% to $776.0 million in 2023, then slipped by 8.12% to $713.0 million in 2024, then increased by 11.22% to $793.0 million in 2025, then slipped by 3.78% to $763.0 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $763.0 million (Q1 2026), $793.0 million (Q4 2025), and $843.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Bausch Health Companies 1.91 Bn 1.58 Bn 2.48 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 763.00 Mn
Dec 31, 2025 793.00 Mn
Sep 30, 2025 843.00 Mn
Jun 30, 2025 877.00 Mn
Mar 31, 2025 761.00 Mn
Dec 31, 2024 713.00 Mn
Sep 30, 2024 805.00 Mn
Jun 30, 2024 745.00 Mn
Mar 31, 2024 751.00 Mn
Dec 31, 2023 776.00 Mn
Sep 30, 2023 721.00 Mn
Jun 30, 2023 745.00 Mn
Mar 31, 2023 746.00 Mn
Dec 31, 2022 741.00 Mn
Sep 30, 2022 619.00 Mn
Jun 30, 2022 524.00 Mn
Mar 31, 2022 544.00 Mn
Dec 31, 2021 653.00 Mn
Sep 30, 2021 872.00 Mn
Jun 30, 2021 975.00 Mn